Spectrum Pharmaceuticals Acquires Talon Therapeutics

Spectrum Pharmaceuticals, Inc.

Represented Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) in its acquisition of Talon Therapeutics, Inc. (OTCQB: TLON), a biopharmaceutical company based in South San Francisco, California. The deal includes upfront payments of approximately $45 million in cash and stock, and future earn-outs of up to $195 million. 

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in oncology and hematology.